Clinical Trial Update: Efficacy and Safety of XH02 for the Treatment of Hypoparathyroidism [EARLY_Phase 1]

View source ↗

Summary

This early-phase trial is evaluating the safety and preliminary efficacy of XH02 for hypoparathyroidism and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• XH02

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Hypoparathyroidism | EARLY_Phase 1 | Status: RECRUITING